BioSpace News Archive

Elpis Biopharmaceuticals, an IND stage biopharmaceutical company developing next generation immunotherapies to transform cancer treatment, today presented two posters at the American Association for Cancer Research (AACR) Annual Meeting, occurring April 8-13, 2022.

Orphagen Pharmaceuticals Inc., a biotech company pioneering the screening, discovery, and development of small molecule ligands that modulate orphan or unexplored members of the nuclear receptor family, today announced a late-breaking presentation of new preclinical data for OR-449 at the American Association for Cancer Research (AACR) Annual Meeting 2022 being held April 8-13 both virtually and in-person in New Orleans.

Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints, today announced two poster presentations on its clinical stage program IO-108, a novel myeloid checkpoint inhibitor targeting Leukocyte Immunoglobulin-Like Receptor B2 (LILRB2, also known as ILT4), at the American Association for Cancer Research (AACR) Annual Meeting.

Xencor Presents Data from Multiple Preclinical XmAb ® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022.

Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced data from the dose escalation phase of the phase 1/2a study with the Company’s Innate Cell Engager (ICE®) AFM24 as monotherapy at the Annual Meeting of the American Association of Cancer Research (AACR).

Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced the presentation of four preclinical data abstracts focused on its natural killer cell platform and pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2022.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the highlights of over 125 studies enabled by NanoString platforms that will be presented at the 2022 meeting of the American Association of Cancer Research, which will be held April 8-13, 2022.

The global pharmacovigilance market size is predicted to rake around USD 18.36 billion by 2030 from valued at USD 5.97 billion in 2020 and expanding growth at a CAGR of 10.6% during the forecast period 2022 to 2030.

The global pharmacy market size was valued at USD 1,009.5 billion in 2020, and is predicted to be worth around USD 1,522.1 billion by 2030, registering a CAGR of 4.8% during the forecast period 2022 to 2030.

Hormonal contraceptive is a reliable way to prevent ovulation and pregnancy. Birth control pill is the most commonly used form of contraception around the world.